Skip to main content

DILLON & ASSOCIATES INC

Position in NVO — Novo Nordisk A S

CIK 1054425 JACKSON, MI

Position in NVO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$2,770,740
-$4,812,585 QoQ
Shares Held
57,796
-72.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#312
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

DILLON & ASSOCIATES INC holds $27,210,293 across 6 Drug Manufacturers - General names. NVO ranks #4 (10.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
57,796 $2,770,740

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,770,740 57,796
2026-03-31 $7,583,325 206,349
2025-12-31 $15,324,954 301,198
2025-09-30 $17,307,331 311,900
2025-06-30 $20,974,004 303,883
2025-03-31 $20,492,716 295,114
2024-12-31 $24,728,685 287,476
2024-09-30 $33,746,462 283,417
2024-06-30 $40,273,520 282,146
2024-03-31 $35,672,986 277,827
2023-12-31 $28,346,127 274,008
2023-09-30 $25,688,458 282,477
2023-06-30 $22,128,310 136,738
2023-03-31 $22,256,842 139,857
2022-12-31 $19,585,863 144,716
2022-09-30 $14,432,202 144,858
2022-06-30 $16,177,184 145,178
2022-03-31 $16,195,643 145,841
2021-12-31 $16,469,712 147,051
2021-09-30 $14,145,249 147,331
2021-06-30 $12,348,954 147,415
2021-03-31 $10,025,758 148,706
2020-12-31 $10,089,902 144,451
2020-09-30 $9,726,587 140,092
2020-06-30 $8,760,241 133,785
2020-03-31 $8,030,860 133,403